Immunovant IMVT Stock
$37.36
-1.942250%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$7.72B
LOW - HIGH [24H]
$37.19
-
$38.62
VOLUME [24H]
$1.03M
P/E Ratio
0
Earnings per share
-$2.81
ISIN
US45258J1025
Immunovant Price Chart
Immunovant IMVT Financial and Trading Overview
| Immunovant stock price | 37.36 USD |
| Previous Close | 38.1 USD |
| Open | 38.62 USD |
| Bid | 27.36 USD x 200 |
| Ask | 47.62 USD x 200 |
| Day's Range | 37.19 - 38.62 USD |
| 52 Week Range | 14.58 - 45.42 USD |
| Volume | 991.19K USD |
| Avg. Volume | 1.25M USD |
| Market Cap | 7.72B USD |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.81 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.88 USD |
IMVT Valuation Measures
| Enterprise Value | 7.07B USD |
| Trailing P/E | N/A |
| Forward P/E | -13.584467 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 10.479664 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -12.503 |
Trading Information
Immunovant Stock Price History
| Beta (5Y Monthly) | 0.81 |
| 52-Week Change | 135.76% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 45.42 USD |
| 52 Week Low | 14.58 USD |
| 50-Day Moving Average | 40.45 USD |
| 200-Day Moving Average | 30.79 USD |
IMVT Share Statistics
| Avg. Volume (3 month) | 1.25M USD |
| Avg. Daily Volume (10-Days) | 1.19M USD |
| Shares Outstanding | 206.55M |
| Float | 91.59M |
| Short Ratio | 14.06 |
| % Held by Insiders | 56.01% |
| % Held by Institutions | 53.98% |
| Shares Short | 15.78M |
| Short % of Float | 16.98% |
| Short % of Shares Outstanding | 7.63% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.73% |
| Return on Equity (ttm) | -80.096% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -565606976 USD |
| Net Income Avi to Common (ttm) | -538217024 USD |
| Diluted EPS (ttm) | -2.81 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 797.8M USD |
| Total Cash Per Share (mrq) | 3.86 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.269 |
| Book Value Per Share (mrq) | 3.565 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -414304000 USD |
| Levered Free Cash Flow (ttm) | -238703632 USD |
Profile of Immunovant
| Country | United States |
| State | NC |
| City | Durham |
| Address | 1000 Park Forty Plaza |
| ZIP | 27713 |
| Phone | 917 410 3120 |
| Website | https://immunovant.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 315 |
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Q&A For Immunovant Stock
What is a current IMVT stock price?
Immunovant IMVT stock price today per share is 37.36 USD.
How to purchase Immunovant stock?
You can buy IMVT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunovant?
The stock symbol or ticker of Immunovant is IMVT.
Which industry does the Immunovant company belong to?
The Immunovant industry is Biotechnology.
How many shares does Immunovant have in circulation?
The max supply of Immunovant shares is 206.55M.
What is Immunovant Price to Earnings Ratio (PE Ratio)?
Immunovant PE Ratio is now.
What was Immunovant earnings per share over the trailing 12 months (TTM)?
Immunovant EPS is -2.81 USD over the trailing 12 months.
Which sector does the Immunovant company belong to?
The Immunovant sector is Healthcare.
Immunovant IMVT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26333.04 USD — |
+0.96
|
5.66B USD — | 26283.11 USD — | 26431.22 USD — | — - | 5.66B USD — |
|
US Tech Real Estate and Other Fi
OFIN
US
|
13444.44 USD — |
+0.5
|
— — | 13378.42 USD — | 13533.84 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12940.54 USD — |
+0.98
|
— — | 12913.4 USD — | 12988.37 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6924.69 USD — |
+0.05
|
— — | 6924.47 USD — | 7006.06 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1293.65 USD — |
+0.08
|
— — | 1293.64 USD — | 1310.12 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
137.24 USD — |
+0.22
|
— — | 137.22 USD — | 139.48 USD — | — - | — — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3079.71 USD — |
+0.6
|
— — | 3078.59 USD — | 3102.26 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
- {{ link.label }} {{link}}
